Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 9/20 | 0.73 |
| ▸ | ACHE | P22303 | 3/20 | 0.73 |
| ▸ | SLC5A1 | P13866 | 2/20 | 0.73 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.73 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.73 |
| ▸ | ESR1 | P03372 | 2/20 | 0.73 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.73 |
| ▸ | BCHE | P06276 | 1/20 | 0.73 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.62 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.62 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.62 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.43 |
| ▸ | PRKCA | P17252 | 1/20 | 0.43 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.43 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.43 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Kushenol N SCHEMBL27013512 | 1.00 | BACE1 (0.73) | BACE1ACHESLC5A1SLC5A2PTGS1 | |
| Kushenol N SCHEMBL564568 | 1.00 | BACE1 (0.73) | BACE1ACHESLC5A1SLC5A2PTGS1 | |
| Kushenol N SCHEMBL564366 | 1.00 | BACE1 (0.73) | BACE1ACHESLC5A1SLC5A2PTGS1 | |
| Kushenol N SCHEMBL27013513 | 1.00 | BACE1 (0.73) | BACE1ACHESLC5A1SLC5A2PTGS1 | |
| Kushenol X SCHEMBL4809925 | 0.91 | BACE1 (0.72) | BACE1ACHESLC5A1SLC5A2PTGS1 | |
| Kushenol K SCHEMBL27013479 | 0.87 | BACE1 (0.72) | BACE1ACHESLC5A1SLC5A2PTGS1 | |
| Kushenol K SCHEMBL564142 | 0.87 | BACE1 (0.72) | BACE1ACHESLC5A1SLC5A2PTGS1 | |
| SCHEMBL564482 | 0.86 | BACE1 (0.57) | BACE1ACHESLC5A1SLC5A2PTGS1 | |
| Kurarinone SCHEMBL10307529 | 0.84 | BACE1 (1.00) | BACE1ACHESLC5A1SLC5A2PTGS1 | |
| Kurarinone SCHEMBL12942466 | 0.84 | BACE1 (1.00) | BACE1ACHESLC5A1SLC5A2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118593712-A | Application of GSK3 beta inhibitor in preparation of medicine for treating sequelae of pelvic inflammatory disease | 黔东南民族职业技术学院 | 2024-09-06 | — | — | CN | claimed |
| CN-111983058-B | Screening method of traditional Chinese medicine anti-nonalcoholic fatty liver active substances | 云南中医药大学 | 2023-06-23 | — | — | CN | claimed |
| CN-119326752-A | Application of kurarinol I in preparing medicine for treating colon cancer | 宁夏医科大学 | 2025-01-21 | — | — | CN | disclosed |
| CN-118593712-A | Application of GSK3 beta inhibitor in preparation of medicine for treating sequelae of pelvic inflammatory disease | 黔东南民族职业技术学院 | 2024-09-06 | — | — | CN | disclosed |
| CN-118593712-A | Application of GSK3 beta inhibitor in preparation of medicine for treating sequelae of pelvic inflammatory disease | 黔东南民族职业技术学院 | 2024-09-06 | — | — | CN | disclosed |
| CN-118304291-A | Application of kuh-seng alcohol I in preparation of medicines for preventing and treating ulcerative colitis | 云南中医药大学 | 2024-07-09 | — | — | CN | disclosed |
| US-20240016777-A1 | COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 2024-01-18 | — | — | US | disclosed |
| CN-111983058-B | Screening method of traditional Chinese medicine anti-nonalcoholic fatty liver active substances | 云南中医药大学 | 2023-06-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240016777-A1 | COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS | THPO, SERPINB1, SERPINC1 | BACE1 3298/4885ACHE 4241/4885SLC5A1 77/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.